NCT03897491View on ClinicalTrials.gov

PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 3, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Glioblastoma
Interventions
DRUG

5-aminolevulinic acid

5-aminolevulinic acid powder for oral solution

Trial Locations (3)

48149

Universitätsklinikum Münster, Münster

50924

Uniklinik Köln, Cologne

81377

Klinikum der Universität München, München

All Listed Sponsors
lead

photonamic GmbH & Co. KG

INDUSTRY